Apr 14, 2022
CEO Matt Mastarone and the TTG Imaging Solutions team started a search for a new capital partner in January of 2021. By May, they were in New York City doing early-look meetings with potential private equity firms its investment banker thought would be interested. In August, the molecular Imaging company had narrowed the search to two firms and were close to getting a deal done; however, supply chain concerns scared those two firms off. As a result, TTG had to come up with a thorough study on its supply chain issues to ease concerns. After doing so, they reengaged another set of bidders and managed to get the deal done in time for Christmas.